The Independent revealed that a recent study found that the enhanced Moderna vaccine may provide protection against Corona variants, and the Minister of Vaccines Nadim Al-Zahawi said that scientists are looking at a range of options, including the new enhanced injections to protect against variants or mixing types of vaccines given, so If the patient has had the AstraZeneca vaccine for their initial doses, they may be given Pfizer as a booster.
The company president confirmed: "We are encouraged by these new data, which strengthens our confidence that our enhanced strategy must be preventive against these newly discovered variants," as a single dose of our enhanced Moderna vaccine showed promising results against the Corona variants that were first discovered in Brazil and South Africa. According to the company behind the vaccine.
The newspaper pointed out that the United Kingdom is in the process of preparing for a third round of "enhanced" strikes across the fall, according to reports, with ministers hoping that this effort will lead to seeing virus rates controllable in a manner similar to influenza.
Now, a small human study by Moderna, the company behind one of the three vaccines circulating in the country, indicated that vaccinations helped increase their immunity against the variant of concern.
The newspaper indicated that the booster doses were given to volunteers who were previously vaccinated with the two-dose Moderna vaccine system, and the preliminary data is the result of an experiment involving 40 people that tested both the current vaccine Moderna and an upgraded version of the South African variant called mRNA-1273.351.
The newspaper said, the company is also working to develop a vaccine that combines the new and existing vaccine.
The results show that while the booster shots of either version of the vaccine increased the antibodies against all variants tested in the experiment, the new booster had a greater response against the South African variant of the original vaccine.
Stefan Bansel, CEO of Moderna, said: “As we strive to defeat the ongoing epidemic, we remain committed to being proactive with the evolution of the Coronavirus, adding,” We have been encouraged by these new data, which reinforces our confidence that our enhanced strategy must be preventive against these newly discovered variables.
He added: "Our mRNA platform allows for the rapid design of candidate vaccines that contain key virus mutations, which could allow the faster development of alternative vaccines matching future variants if needed."
It comes as trials are underway to assess the most effective way to immunize the UK's most vulnerable age groups over the course of the autumn months to stem another spike in cases during the winter.
Vaccination Minister Nadim Al-Zahawi said that scientists are looking at a range of options, including new injections to protect against variants or mixing the types of vaccines given, so if a patient had taken the AstraZeneca vaccine for its initial doses, it could be given Pfizer as a booster.
“We want them to be able, if they need to, from September onwards to strengthen the most vulnerable,” Al-Zahawi added.
The government has already requested 60 million doses of the Pfizer vaccine in preparation for a boost campaign. "Doctors have not made the decision yet, to administer the booster doses, either to give more immunity to the most vulnerable, or to increase the durability of protection or to deal with the alternative."
Comments
Post a Comment